论文部分内容阅读
在我国,发展低碳经济已提升至国家层面,成为调整产业结构和产业升级的主攻方向。作为关系民众健康的我国医药产业却仍大多存在高能耗、高排放、高污染的非低碳生产运作模式。本文通过分析低碳经济下,我国制药产业面临的挑战与机遇,提出政府引导企业低碳转型的建议及制药企业低碳化发展的对策。
In our country, the development of a low-carbon economy has been promoted to the national level and has become the main direction of adjustment of industrial structure and industrial upgrading. As the relationship between people’s health, most of the pharmaceutical industry in our country still have non-low-carbon production and operation mode with high energy consumption, high emission and high pollution. By analyzing the challenges and opportunities that our country’s pharmaceutical industry faces under the low-carbon economy, this article puts forward the government’s suggestions on how to guide the low-carbon transformation of the enterprises and the countermeasures for the development of low-carbon pharmaceutical enterprises.